Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 2, pp. 391-397
PubMed
Published By
Print ISSN
Online ISSN
History
- December 21, 2007
- May 1, 2007
- December 5, 2007
- Published first February 1, 2008.
Article Versions
- Previous version (February 1, 2008 - 13:23).
- You are viewing the most recent version of this article.
Copyright & Usage
American Association for Cancer Research
Author Information
- Elizabeth A. Duncan1,
- Christine A. Goetz1,
- Sarah J. Stein12,
- Katie J. Mayo3,
- Brian J. Skaggs4,
- Karl Ziegelbauer5,
- Charles L. Sawyers6 and
- Albert S. Baldwin123
- 1Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine; 2Department of Biology and 3Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, North Carolina; 4University of California-Los Angeles School of Medicine, Los Angeles, California; 5Bayer Healthcare, Wuppertal, Germany; and 6Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
- Requests for reprints: Albert S. Baldwin, 22-000 Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7295. Phone: 919-966-3652; Fax: 919-966-8212. E-mail: abaldwin{at}med.unc.edu
February 2008
Volume 7, Issue 2
Volume 7, Issue 2
IκB kinase β inhibition induces cell death in Imatinib-resistant and T315I Dasatinib-resistant BCR-ABL+ cells
Jump to section
Advertisement